What Is Coagulase-Negative Staphylococcus?

The human body is home to countless microscopic organisms, a diverse community primarily composed of bacteria. While many bacterial species coexist harmlessly with humans and even provide benefits, some possess the capacity to cause infections. Understanding these microorganisms is important, as it helps distinguish between beneficial inhabitants and potential threats.

Understanding Coagulase-Negative Staphylococcus

Coagulase-Negative Staphylococcus (CoNS) refers to a group of bacteria within the Staphylococcus genus that do not produce the coagulase enzyme. This distinguishes them from Staphylococcus aureus, a more commonly known and often more virulent species that does produce coagulase. The coagulase enzyme causes blood plasma to clot by converting fibrinogen into fibrin, a process CoNS cannot perform.

CoNS are widely prevalent and a significant component of the normal flora on human skin and mucous membranes. Many species exist, with Staphylococcus epidermidis being one of the most common. Other notable species include Staphylococcus saprophyticus, Staphylococcus lugdunensis, and Staphylococcus haemolyticus. These species inhabit various body areas; for instance, S. epidermidis is found in humid areas, and S. saprophyticus can be part of the normal vaginal flora.

When Coagulase-Negative Staphylococcus Causes Infection

While CoNS are typically benign, they can become opportunistic pathogens under specific conditions. Infections often arise when the body’s natural barriers are breached, such as during surgical procedures, or when the immune system is weakened. The presence of medical devices, including catheters, prosthetic joints, and heart valves, significantly increases the risk of CoNS infections. These bacteria can adhere to device surfaces and form complex communities called biofilms.

Biofilms are protective layers that shield bacteria from immune defenses and make them less susceptible to antibiotics, rendering infections difficult to eradicate. Common CoNS infections include bloodstream infections, surgical site infections, and medical implant-related infections. S. epidermidis frequently causes device-related infections. S. saprophyticus is a common cause of urinary tract infections. Some CoNS species, like Staphylococcus lugdunensis, can cause more severe infections, including endocarditis, similar to those caused by Staphylococcus aureus.

A growing concern with CoNS infections is their increasing resistance to multiple antibiotics. Many strains, particularly those acquired in healthcare settings, show high rates of resistance to commonly used antibiotics, including methicillin. This resistance complicates treatment, often necessitating second-line antimicrobial drugs. The ability of CoNS to form biofilms and their widespread antibiotic resistance make them challenging pathogens in clinical practice.

Detecting and Treating Coagulase-Negative Staphylococcus Infections

Identifying CoNS infections typically involves laboratory analysis of patient samples. Microbiologists perform a coagulase test, which determines if the bacteria produce the coagulase enzyme. A negative result confirms CoNS. Further identification to the species level, such as S. epidermidis or S. saprophyticus, may be performed using other biochemical tests or molecular methods.

Treatment strategies for CoNS infections usually involve antibiotic therapy. However, due to the high prevalence of antibiotic resistance among CoNS, susceptibility testing is crucial to guide treatment decisions. This testing helps determine which antibiotics will be effective against the specific strain causing the infection. For many serious CoNS infections, particularly those involving medical devices, removal of the infected device is often a necessary component of treatment, alongside antibiotics.

Vancomycin is frequently used as an initial antibiotic for CoNS infections, especially when methicillin resistance is suspected. Other antibiotics like daptomycin or linezolid may be considered, particularly for resistant strains. The duration of antibiotic treatment can vary depending on the infection site and severity, ranging from several days for uncomplicated cases to weeks for deep-seated infections or those involving retained medical devices.